Fu W - Search Results

1

Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.

He H, Li Z, Lu J, Qiang W, Jiang S, Xu Y, Fu W, Zhai X, Zhou L, Qian M, Du J. He H, et al. Among authors: fu w. Clin Transl Med. 2022 Mar;12(3):e757. doi: 10.1002/ctm2.757. Clin Transl Med. 2022. PMID: 35297204 Free PMC article.

2

[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].

Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J. Tao ZF, et al. Ai Zheng. 2006 Apr;25(4):461-4. Ai Zheng. 2006. PMID: 16613681 Chinese.

3

Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: a clinical study of 110 patients in China.

Li Y, Hou J, Wang D, Fu W, Yuan Z, Chen Y, Tao Z. Li Y, et al. Among authors: fu w. Leuk Lymphoma. 2006 Dec;47(12):2593-600. doi: 10.1080/10428190600955753. Leuk Lymphoma. 2006. PMID: 17169804

4

Prognostic factors and staging systems of multiple myeloma:

Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J. Tao ZF, et al. Chin Med J (Engl). 2007 Oct 5;120(19):1655-8. Chin Med J (Engl). 2007. PMID: 17935664

5

[Clinical features of multiple myeloma patients with extramedullary disease: a report of 40 cases from a single center].

Chen HF, Fu WJ, Wang DX, Yuan ZG, Chen YB, Hou J. Chen HF, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):655-8. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399168 Chinese.

6

[The impact of autologous stem cell transplantation on the prognosis in multiple myeloma].

Li YH, Hou J, Wang DX, Fu WJ, Yuan ZG, Chen YB, Xi H. Li YH, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):222-5. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843973 Chinese.

7

[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].

DU J, Yuan ZG, Zhang CY, Fu WJ, Jiang H, Chen BA, Hou J. DU J, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Oct;30(10):649-53. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954656 Chinese.

8

Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.

Du J, Yuan Z, Zhang C, Fu W, Jiang H, Chen B, Hou J. Du J, et al. Among authors: fu w. Leuk Res. 2010 Nov;34(11):1453-8. doi: 10.1016/j.leukres.2010.01.011. Epub 2010 Jan 31. Leuk Res. 2010. PMID: 20122728

9

Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.

Du J, Huo J, Shi J, Yuan Z, Zhang C, Fu W, Jiang H, Yi Q, Hou J. Du J, et al. Among authors: fu w. Haematologica. 2011 May;96(5):729-37. doi: 10.3324/haematol.2010.030577. Epub 2011 Jan 12. Haematologica. 2011. PMID: 21228035 Free PMC article.

10

Clinical effects of autologous stem cell transplantation as consolidation treatment in 70 multiple myeloma patients: a case-controlled study.

Zhou LL, Yuan ZG, Fu WJ, Xi H, Zhang CY, Lan HF, Zhang X, Chen Y, Liu WY, Hou J. Zhou LL, et al. Chin Med J (Engl). 2011 Oct;124(19):2975-80. Chin Med J (Engl). 2011. PMID: 22040538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,318 results

Search Page

Filters